Schedule 13G ownership disclosure
ADURO BIOTECH, INC.
Security class unavailable · CUSIP: 00739L101
Event date: 2017-12-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,170,528
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-074069
- Form type
- SC 13G
- Filer
- CHINOOK THERAPEUTICS, INC.
- CIK
- CIK 1435049
- Filed
- Dec 19, 2017
- Reporting period
- Dec 19, 2017
- Description
- Schedule 13G beneficial ownership